Popular Searches:

drugs

viagra

diet pills
drugs prescription drugs weight loss drugs drugs online discount drugs drugstore drugs for depression online drugstore online drugs canadian drugs cheap drugs nc drugs facilities fertility drugs canada drugs brands only drugs acyclovir adipex ambien antibiotic carisoprodol celebrex didrex diet pills discount xenical hydrocodone ionamin lortab meridia online soma paxil penis enlargement phentermine prevacid prilosec propecia prozac renova retin-a senior health soma sonata tenuate tramadol ultram valium valtrex vaniqa viagra vicodin vioxx vitamin wagering weight weight loss wellbutrin women health xanax xenical xenical online zocor zoloft zovirax zyban zyrtec
A1, A2, B, C1, C2, D, E, F, G-H, I-K, L, M, N, O, P1, P2, Q-R, S, T, U-V, W-Z

Ferrlecit Indications, Dosage, Storage, Stability - Sodium ferric gluconate

Ferrlecit Indications, Dosage, Storage, Stability - Sodium ferric gluconate

INDICATIONS

AND USAGE

Ferrlecit® is indicated for treatment of iron deficiency in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy.

DOSAGE AND ADMINISTRATION

The dosage of Ferrlecit® is expressed in terms of mg of elemental iron. Each 5ml ampule contains 62.5mg of elemental iron (12.5mg/ml).

Before initiating therapeutic doses of Ferrlecit®, administration of an intravenous test dose of 2ml Ferrlecit® (25 mg of elemental iron) is recommended. This test dose should be diluted in 50ml of 0.9% sodium chloride for injection and administered over sixty minutes.

The recommended dosage of Ferrlecit® for the repletion treatment of iron deficiency in hemodialysis patients is 10ml of Ferrlecit® (125mg of elemental iron) diluted in 100 mL of 0.9% sodium chloride for injection, administered by intravenous infusion over 1 hour. Most patients will require a minimum cumulative dose of 1.0 gram of elemental iron, administered over eight sessions at sequential dialysis treatments, to achieve a favorable hemoglobin or hematocrit response. Patients may continue to require therapy with Ferrlecit® or other intravenous iron preparations at the lowest dose necessary to maintain the target levels of hemoglobin, hematocrit, and laboratory parameters of iron storage within acceptable limits.

Ferrlecit® has been administered at sequential dialysis sessions by infusion during the dialysis session itself.

Note: Do not mix Ferrlecit® with other medications, or add to parenteral nutrition solutions for intravenous infusion. The compatibility of Ferrlecit® with intravenous infusion vehicles other than 0.9% sodium chloride for injection has not been evaluated. Parenteral drug products should be inspected visually for particulate matter and discoloration before administration, whenever the solution and container permit.

Use immediately after dilution in saline.

HOW SUPPLIED

Ferrlecit® is supplied in colorless glass ampules containing a viscous dark red solution with no visible particulate matter. Each ampule contains 62.5 mg of elemental iron in 5 mL for intravenous use, packaged in cartons of 10 ampules.

Store at 20oC-25oC (68oF-77oF); excursions permitted to 15-30oC (59-86oF). See USP Controlled Room Temperature.

Caution: Rx Only

© Schein Pharmaceutical, Inc., and R&D Laboratories, Inc. 1998. [Schein Pharmaceutical, Inc. Logo] [R&D Laboratories, Inc. Logo]

February 18, 1999 NDA 20-955 Ferrlecit

top


Popular Searches:

weight loss

ultram

penis enlargement

hydrocodone

antibiotic